The proposal from the Centers for Medicare & Medicaid Services to codify the requirement that all Medicare Advantage plans use the Two-Midnight Rule for determining admission status of all patients has some talking that the use of commercial criteria will become obsolete. ...
R1’s comprehensive revenue cycle solutions for physician groups continue to draw acclaim from healthcare industry experts and praise from the partners we serve. For the third consecutive year, R1 has been named best in KLAS for Ambulatory Revenue Cycle Management (RCM) Services.
While the healthcare industry continues to climb its way out of a pandemic, it’s also facing unprecedented challenges, including rising operating costs, labor shortages and shrinking margins. What if there was a global delivery model that could help the industry during this challenging time?
The health system’s vice president of emergency services speaks out to patients who still may be uncomfortable with getting necessary care, noting recent innovations that will protect them
CHICAGO, February 8, 2019 – R1 RCM Inc. (NASDAQ:RCM), a leader in technology-enabled revenue cycle management ...
CHICAGO – October 19, 2018 – R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, announced today that R1 Analytics, the company’s proprietary performance ...
Revenue-cycle management company R1 RCM continued to grow its revenue in the second quarter of 2018, and the company said that will continue through the end of the year as it brings on new customers.
Healthcare Informatics named R1 RCM to its Top 100 companies in Healthcare IT Products & Services list for 2017. R1 came in at number 52 for it’s first year on the Top 100.
CHICAGO, May 8, 2018 – R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced it has completed its acquisition of Intermedix Corporation.
CHICAGO, March 20, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (“R1” or the “Company”) (NASDAQ:RCM), a leading provider of technology-enabled revenue cycle management services to healthcare providers, today announced it has received approval for its common shares to trade on the Nasdaq Global Market effective at market open on March 21, ...
© 2021 R1 RCM, Inc. All rights reserved.